Success Story: We Helped A Neuropsychiatric Genetics Expert Secure An NIW Success
Client’s Testimonial:
"Working with Chen Immigration was a great experience while filing my NIW petition during a busy PhD program. The team was very professional in drafting all required documents and efficient in communication and customization. I was grateful that the petition package itself was not challenged, despite the heightened scrutiny in the current immigration environment. I would highly recommend working with Chen and wish everyone success with their filing.”
On June 6th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student in the Field of Neuropsychiatric Genetics (Approval Notice).
General Field: Neuropsychiatric Genetics
Position at the Time of Case Filing: Graduate Student
Country of Origin: Taiwan
State of Residence at the Time of Filing: Texas
Approval Notice Date: June 6th, 2026
Processing Time: 5 months, 25 days (Premium Processing Requested)
Case Summary:
We are pleased to share that North America Immigration Law Group successfully secured I-140 National Interest Waiver approval for a client in the field of neuropsychiatric genetics. The client holds a master’s degree in brain and mind sciences and is currently continuing research at a U.S. medical research institution. We prepared a focused petition demonstrating the national importance of her work and her strong positioning to advance it.
The client’s proposed endeavor is to continue evaluating the liability of neuropsychiatric disorders by developing individualized genetic risk prediction models. Through this work, she aims to inform early clinical decisions and improve health outcomes for high-risk populations.
In the petition, we demonstrated that the client’s work addresses an important need in mental healthcare. Her research focuses on improving risk prediction for neuropsychiatric disorders, including through ancestry-informed genetic models and studies of how genetic factors relate to mental illness. We also emphasized that her work is nationally significant because it supports more personalized approaches to mental health evaluation, helps address gaps in existing genetic research, and contributes to areas such as bioinformatics, computational biology, predictive modeling, and health innovation.
The client’s record included:
- 7 peer-reviewed journal articles, including 4 first-authored or co-first-authored articles
- 2 preprints, including 1 first-authored preprint
- 165 citations to her published body of work
- 4 completed peer reviews
- Evidence of major funding support from the National Human Genome Research Institute
We presented these credentials as evidence of recognized influence rather than as numbers alone. The citation record showed that other researchers had relied on the client’s findings in their own studies, including work involving neurodevelopmental genetics, depression and insomnia, and psychiatric genetics across diverse populations. Her peer-review activity also helped show that journals trusted her expertise to evaluate research in the field. The funding evidence further supported the importance of her research direction by showing that her work aligned with nationally relevant genomic research priorities.
This I-140 NIW approval reflects the strength of a carefully prepared petition that connected the client’s research record, peer recognition, and future plans to a nationally important endeavor. By showing how her work advances individualized genetic risk prediction and supports improved mental healthcare outcomes, we established that the client is well-positioned to continue contributing to neuropsychiatric genetics in the United States. We congratulate the client on this approval and wish her continued success in her important research.